Pathophysiology vascular disease diabetes effects gliclazide mellitus major risk factor coronary heart disease peripheral vascular disease cardiovascular disease prevalence complications two- four-fold people diabetes United morbidity mortality healthcare costs pathogenesis macrovascular disease diabetes multifactorial Endothelial injury early event macrophage adherence uptake lipids fatty streak Platelet adherence aggregation release thromboxane platelet-derived growth factors Quantitative qualitative alterations lipoproteins uncontrolled insulin-dependent non-insulin-dependent diabetes Hyperinsulinemia contributory plasma proinsulin levels Glycation plasma proteins components vascular wall coagulation fibrinolysis process hypertension smoking hypercholesterolemia Gliclazide oral sulfonylurea agent actions platelet function fibrinolysis addition effects glycemia evidence recommendations future studies 